1. Much More than M1 and M2 Macrophages, There are also CD169+ and TCR+ Macrophages
    Leslie Chávez-Galán et al, 2015, Front. Immunol. CrossRef
  2. Small cell lung cancer: Recruitment of macrophages by circulating tumor cells
    Gerhard Hamilton et al, 2016, OncoImmunology CrossRef
  3. Regulation of EMT by STAT3 in gastrointestinal cancer (Review)
    Bo Li et al, 2017 CrossRef
  4. Anticancer effect of luteolin is mediated by downregulation of TAM receptor tyrosine kinases, but not interleukin-8, in non-small cell lung cancer cells
    Youn Ju Lee et al, 2017 CrossRef
  5. IL-8 suppresses E-cadherin expression in nasopharyngeal carcinoma cells by enhancing E-cadherin promoter DNA methylation
    RUI-LI ZHANG et al, 2016 CrossRef
  6. IL-8, a novel messenger to cross-link inflammation and tumor EMT via autocrine and paracrine pathways (Review)
    XINXIN LONG et al, 2016 CrossRef
  7. Downregulated connexin32 promotes EMT through the Wnt/β-catenin pathway by targeting Snail expression in hepatocellular carcinoma
    Yan Yang et al, 2017 CrossRef
  8. Translational Significance for Tumor Metastasis of Tumor-Associated Macrophages and Epithelial–Mesenchymal Transition
    Wenzhe Song et al, 2017, Front. Immunol. CrossRef
  9. Differential Serum Cytokine Profiles in Patients with Chronic Hepatitis B, C, and Hepatocellular Carcinoma
    Jacqueline Estevez et al, 2017, Sci Rep CrossRef
  10. MicroRNA-30a suppresses autophagy-mediated anoikis resistance and metastasis in hepatocellular carcinoma.
    Xiu-Tao Fu et al, 2018, Cancer Lett CrossRef
  11. Janus kinase inhibitors prevent migration of rheumatoid arthritis neutrophils towards interleukin-8, but do not inhibit priming of the respiratory burst or reactive oxygen species production
    T. S. Mitchell et al, 2017, Clin Exp Immunol CrossRef
  12. Irisin reverses the IL-6 induced epithelial-mesenchymal transition in osteosarcoma cell migration and invasion through the STAT3/Snail signaling pathway
    Gang Kong et al, 2017 CrossRef
  13. New Insights into the Tumor Microenvironment Utilizing Protein Array Technology
    Wei Huang et al, 2018, IJMS CrossRef
  14. Role of nonresolving inflammation in hepatocellular carcinoma development and progression
    Le-Xing Yu et al, 2018, npj Precision Onc CrossRef
  15. LncRNA TUG1 interacting with miR-144 contributes to proliferation, migration and tumorigenesis through activating the JAK2/STAT3 pathway in hepatocellular carcinoma.
    Jun Lv et al, 2018, Int J Biochem Cell Biol CrossRef
  16. Essential genes of the macrophage response to Staphylococcus aureus exposure
    Aixia Sun et al, 2018, Cell Mol Biol Lett CrossRef
  17. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma
    Ya-Dong Wang et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  18. Abnormally expressed JunB transactivated by IL-6/STAT3 signaling promotes uveal melanoma aggressiveness via epithelial–mesenchymal transition
    Chaoju Gong et al, 2018, Biosci. Rep. CrossRef
  19. MiR-221 mediates the epithelial-mesenchymal transition of hepatocellular carcinoma by targeting AdipoR1
    Tong Li et al, 2017, International Journal of Biological Macromolecules CrossRef
  20. Relationship between epithelial-to-mesenchymal transition and the inflammatory microenvironment of hepatocellular carcinoma
    Long Yan et al, 2018, J Exp Clin Cancer Res CrossRef
  21. The Interplay between Circulating Tumor Cells and the Immune System: From Immune Escape to Cancer Immunotherapy
    Kevin Leone et al, 2018, Diagnostics CrossRef
  22. Tumor-driven like macrophages induced by conditioned media from pancreatic ductal adenocarcinoma promote tumor metastasis via secreting IL-8
    Shao-jie Chen et al, 2018, Cancer Med CrossRef
  23. Epithelial-Mesenchymal Transition: Initiation by cues from chronic inflammatory tumor microenvironment and termination by anti-inflammatory compounds and specialized pro-resolving lipids
    Chang Hoon Lee, 2018, Biochemical Pharmacology CrossRef
  24. Traditional Chinese medicine as targeted treatment for epithelial-mesenchymal transition-induced cancer progression
    Jianrong Liu et al, 2018, J Cell Biochem CrossRef
  25. IL-8 Secreted from M2 Macrophages Promoted Prostate Tumorigenesis via STAT3/MALAT1 Pathway
    Tingjin Zheng et al, 2018, IJMS CrossRef
  26. Blastemal progenitors modulate immune signaling during early limb regeneration
    Stephanie L. Tsai et al, 2019, Development CrossRef
  27. TNF-α derived from M2 tumor-associated macrophages promotes epithelial-mesenchymal transition and cancer stemness through the Wnt/β-catenin pathway in SMMC-7721 hepatocellular carcinoma cells
    Yongxu Chen et al, 2019, Experimental Cell Research CrossRef
  28. Diverging inflammasome signals in tumorigenesis and potential targeting.
    Rajendra Karki et al, 2019, Nat Rev Cancer CrossRef
  29. Predictive value of intratumour inflammatory cytokine mRNA levels of hepatocellular carcinoma patients and activation of two distinct pathways govern IL-8 induced epithelial-mesenchymal transition in human hepatic cancer cell lines
    Siqi Peng et al, 2019, Cytokine CrossRef
  30. Tumor-associated macrophages modulate resistance to oxaliplatin via inducing autophagy in hepatocellular carcinoma
    Xiu-Tao Fu et al, 2019, Cancer Cell Int CrossRef
  31. An immunosuppressive peptide from the horsefly inhibits inflammation by repressing macrophage maturation and phagocytosis
    Ran Chen et al, 2019, J Cell Biochem CrossRef
  32. STAT3 integrates cooperative Ras and TGF-β signals that induce Snail expression
    M Saitoh et al, 2016, Oncogene CrossRef
  33. Whom to blame for metastasis, the epithelial–mesenchymal transition or the tumor microenvironment?
    M. Pietilä et al, 2016, Cancer Letters CrossRef
  34. Type conversion of secretomes in a 3D TAM2 and HCC cell co-culture system and functional importance of CXCL2 in HCC
    Yu Lu et al, 2016, Sci Rep CrossRef
  35. null
    Arthur Zimmermann, 2016 CrossRef
  36. The Vicious Cross-Talk between Tumor Cells with an EMT Phenotype and Cells of the Immune System
    Elisabetta Romeo et al, 2019, Cells CrossRef
  37. Association of tumour-associated macrophages with cancer cell EMT, invasion, and metastasis of Kazakh oesophageal squamous cell cancer
    Jihong Liu et al, 2019, Diagn Pathol CrossRef
  38. FEZF1-AS1: a novel vital oncogenic lncRNA in multiple human malignancies
    Changlong Shi et al, 2019, Biosci. Rep. CrossRef
  39. Hepatocellular carcinoma: Mechanisms of progression and immunotherapy.
    Yu Jiang et al, 2019, World J Gastroenterol CrossRef
  40. Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications.
    Yuxin Lin et al, 2019, J Hematol Oncol CrossRef
  41. Cell Stemness, Epithelial-to-Mesenchymal Transition, and Immunoevasion: Intertwined Aspects in Cancer Metastasis
    Simona Romano et al, 2019, Seminars in Cancer Biology CrossRef
  42. A novel role of the checkpoint kinase ATR in leptin signaling
    Elke Ericson et al, 2015, Molecular and Cellular Endocrinology CrossRef
  43. Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages
    Stefano Ugel et al, 2015 CrossRef
  44. Tumor-associated macrophages correlate with the clinicopathological features and poor outcomes via inducing epithelial to mesenchymal transition in oral squamous cell carcinoma
    Yong Hu et al, 2016, J Exp Clin Cancer Res CrossRef
  45. null
    Tobias Flecken et al, 2016 CrossRef
  46. null
    Arthur Zimmermann, 2017 CrossRef
  47. Pharmacological and immunological targeting of tumor mesenchymalization
    Justin M. David et al, 2017, Pharmacology & Therapeutics CrossRef
  48. MicroRNA-500a promotes migration and invasion in hepatocellular carcinoma by activating the Wnt/β-catenin signaling pathway
    Yuntao Guo et al, 2017, Biomedicine & Pharmacotherapy CrossRef
  49. EMT and inflammation: inseparable actors of cancer progression.
    Meggy Suarez-Carmona et al, 2017, Mol Oncol CrossRef
  50. Fusion of macrophages promotes breast cancer cell proliferation, migration and invasion through activating epithelial-mesenchymal transition and Wnt/β-catenin signaling pathway
    Li-Na Zhang et al, 2019, Archives of Biochemistry and Biophysics CrossRef
  51. Neuroendocrine Regulation of Tumor-Associated Immune Cells
    Claudia B. Colon-Echevarria et al, 2019, Front. Oncol. CrossRef
  52. Reversal of Epithelial–Mesenchymal Transition by Natural Anti-Inflammatory and Pro-Resolving Lipids
    null Lee, 2019, Cancers CrossRef
  53. PM2.5, Fine Particulate Matter: A Novel Player in the Epithelial-Mesenchymal Transition?
    Zihan Xu et al, 2019, Front. Physiol. CrossRef
  54. Trained Immunity for Personalized Cancer Immunotherapy: Current Knowledge and Future Opportunities
    Joana R. Lérias et al, 2020, Front. Microbiol. CrossRef
  55. TRIM27 promotes IL-6-induced proliferation and inflammation factor production by activating STAT3 signaling in HaCaT cells.
    Xiao Miao et al, 2020, Am J Physiol Cell Physiol CrossRef
  56. Targeting cancer stem cell pathways for cancer therapy
    Liqun Yang et al, 2020, Sig Transduct Target Ther CrossRef
  57. Tubular STAT3 Limits Renal Inflammation in Autosomal Dominant Polycystic Kidney Disease
    Amandine Viau et al, 2020, JASN CrossRef
  58. Integrated in silico and 3D in vitro model of macrophage migration in response to physical and chemical factors in the tumor microenvironment
    Sharon Wei Ling Lee et al, 2020 CrossRef
  59. Epithelial-Mesenchymal Transition in Cancer: A Historical Overview
    Domenico Ribatti et al, 2020, Translational Oncology CrossRef
  60. Myeloid Cells in Metastasis
    Agnieszka Swierczak et al, 2020, Cold Spring Harb Perspect Med CrossRef
  61. The roles of tumor-associated macrophages in tumor angiogenesis and metastasis.
    Luo-Qin Fu et al, 2020, Cell Immunol CrossRef
  62. Reduced expression of CD109 in tumor-associated endothelial cells promotes tumor progression by paracrine interleukin-8 in hepatocellular carcinoma
    Bo-Gen Ye et al, 2016, Oncotarget CrossRef
  63. MicroRNA-216a inhibits the metastasis of gastric cancer cells by targeting JAK2/STAT3-mediated EMT process
    Youmao Tao et al, 2017, Oncotarget CrossRef
  64. Sohlh2 suppresses epithelial to mesenchymal transition in breast cancer via downregulation of IL-8
    Shufang Ji et al, 2016, Oncotarget CrossRef
  65. Lung cancer exosomes as drivers of epithelial mesenchymal transition
    Mohammad A. Rahman et al, 2016, Oncotarget CrossRef
  66. Targeting tumor-associated macrophages to combat pancreatic cancer
    Ran Cui et al, 2016, Oncotarget CrossRef
  67. Modulation of the tumor microenvironment by natural agents: implications for cancer prevention and therapy
    Haseeb Zubair et al, 2020, Seminars in Cancer Biology CrossRef
  68. CXCL1 stimulates migration and invasion in ER‑negative breast cancer cells via activation of the ERK/MMP2/9 signaling axis
    Chengcheng Yang et al, 2019, Int J Oncol CrossRef
  69. An overview of the role of interleukin-8 in colorectal cancer
    Soroush Najdaghi et al, 2020, Cytokine CrossRef
  70. Senescent hepatic stellate cells caused by deoxycholic acid modulates malignant behavior of hepatocellular carcinoma
    Phuong Thao Nguyen et al, 2020, J Cancer Res Clin Oncol CrossRef
  71. Macrophage Polarization in Chronic Lymphocytic Leukemia: Nurse-Like Cells Are the Caretakers of Leukemic Cells
    Oana Mesaros et al, 2020, Biomedicines CrossRef
  72. Targeting tumor-associated macrophages as an antitumor strategy
    Nan Cheng et al, 2020, Biochemical Pharmacology CrossRef
  73. HER2 overexpression triggers the IL-8 to promote arsenic-induced EMT and stem cell-like phenotypes in human bladder epithelial cells
    Qing Zhou et al, 2021, Ecotoxicology and Environmental Safety CrossRef
  74. Ascochlorin Enhances the Sensitivity of Doxorubicin Leading to the Reversal of Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma
    Xiaoyun Dai et al, 2016, Mol Cancer Ther CrossRef
  75. MIF-Induced Stromal PKCβ/IL8 Is Essential in Human Acute Myeloid Leukemia
    Amina M. Abdul-Aziz et al, 2017, Cancer Res CrossRef
  76. Is There a Place for Immune Checkpoint Inhibitors in Vulvar Neoplasms? A State of the Art Review
    Fulvio Borella et al, 2020, IJMS CrossRef
  77. Cancer Immunology and Immuno-Oncology (Innate vs. Adaptive Cell Immunity)
    Nariman Nezami et al, 2020, Digestive Disease Interventions CrossRef
  78. Research trends in pharmacological modulation of tumor-associated macrophages.
    Neng Wang et al, 2021, Clin Transl Med CrossRef
  79. TGFβ signaling networks in ovarian cancer progression and plasticity
    Asha Kumari et al, 2021, Clin Exp Metastasis CrossRef
  80. Non-invasive detection of epithelial mesenchymal transition phenotype and metastatic dissemination of lung cancer by liquid biopsy
    Viviana De Rosa et al, 2021 CrossRef
  81. Mechanisms of Macrophage Plasticity in the Tumor Environment: Manipulating Activation State to Improve Outcomes
    Tiffany Davia Ricketts et al, 2021, Front. Immunol. CrossRef
  82. Claudin-Low Breast Cancer Inflammatory Signatures Support Polarization of M1-Like Macrophages with Protumoral Activity
    Mayra Cecilia Suárez-Arriaga et al, 2021, Cancers CrossRef
  83. Epithelial-to-Mesenchymal Transition in the Light of Plasticity and Hybrid E/M States
    Laura Bornes et al, 2021, JCM CrossRef
  84. Conophylline Inhibits Hepatocellular Carcinoma by Inhibiting Activated Cancer-associated Fibroblasts Through Suppression of G Protein–coupled Receptor 68
    Takahiro Yamanaka et al, 2021, Mol Cancer Ther CrossRef
  85. Role of tumor‐associated macrophages at the invasive front in human colorectal cancer progression
    Katsuaki Inagaki et al, 2021, Cancer Sci CrossRef
  86. Exploring the Crosstalk between Inflammation and Epithelial-Mesenchymal Transition in Cancer
    Indranil Chattopadhyay et al, 2021, Mediators of Inflammation CrossRef
  87. The Many Faces of JAKs and STATs Within the COVID-19 Storm
    Alice H. Grant et al, 2021, Front. Immunol. CrossRef
  88. Tumor-Associated Macrophages in Hepatocellular Carcinoma: Friend or Foe?
    Dexi Zhou et al, 2021, Gut and Liver CrossRef
  89. Analysis and Validation of Human Targets and Treatments Using a Hepatocellular Carcinoma–Immune Humanized Mouse Model
    Yue Zhao et al, 2021, Hepatology CrossRef
  90. Macrophage targeting in cancer.
    Martha Lopez-Yrigoyen et al, 2021, Ann N Y Acad Sci CrossRef
  91. Identification and validation of a novel immune-related signature associated with macrophages and CD8 T cell infiltration predicting overall survival for hepatocellular carcinoma
    Junyu Huo et al, 2021, BMC Med Genomics CrossRef
  92. Understanding and Improving Cellular Immunotherapies Against Cancer: From Cell-Manufacturing to Tumor-Immune Models
    Rachel Ringquist et al, 2021, Advanced Drug Delivery Reviews CrossRef
  93. Dysbiosis of Gut Microbiota Promotes Hepatocellular Carcinoma Progression by Regulating the Immune Response
    Nan Zhang et al, 2021, Journal of Immunology Research CrossRef
  94. null
    Biswatrish Sarkar et al, 2021 CrossRef
  95. null
    Biswatrish Sarkar et al, 2021 CrossRef
  96. Taxus wallichiana var. chinensis (Pilg.) Florin Aqueous Extract Suppresses the Proliferation and Metastasis in Lung Carcinoma via JAK/STAT3 Signaling Pathway
    Leitao Sun et al, 2021, Front. Pharmacol. CrossRef
  97. Evaluation of the Anti-Inflammatory and Anti-Oxidative Effects of Therapeutic Human Lactoferrin Fragments
    Yu Pan et al, 2021, Front. Bioeng. Biotechnol. CrossRef
  98. CKLF-Like MARVEL Transmembrane Domain-Containing Member 3 (CMTM3) Inhibits the Proliferation and Tumorigenisis in Hepatocellular Carcinoma Cells
    Wujun Li et al, 2017, oncol res CrossRef
  99. Tumor metastasis: Mechanistic insights and therapeutic interventions
    Mengmeng Liu et al, 2021, MedComm CrossRef
  100. Roles of the CXCL8-CXCR1/2 Axis in the Tumor Microenvironment and Immunotherapy
    Zhi-Jian Han et al, 2021, Molecules CrossRef
  101. Roles of tumor-associated macrophages in tumor progression: implications on therapeutic strategies
    Shangli Zhu et al, 2021, Exp Hematol Oncol CrossRef
  102. PADI4 promotes epithelial-mesenchymal transition(EMT) in gastric cancer via the upregulation of interleukin 8
    Xiao-tian Chang et al, 2022, BMC Gastroenterol CrossRef
  103. Crosstalk between ferroptosis and the epithelial-mesenchymal transition: implications for inflammation and cancer therapy
    Nasim Ebrahimi et al, 2022, Cytokine & Growth Factor Reviews CrossRef
  104. null
    Biswatrish Sarkar et al, 2022 CrossRef
  105. Tumor-associated macrophages, dendritic cells, and neutrophils: biological roles, crosstalk, and therapeutic relevance
    Mingyi Shen et al, 2022 CrossRef
  106. 18β-Glycyrrhetinic Acid Inhibits TGF-β-Induced Epithelial-to-Mesenchymal Transition and Metastasis of Hepatocellular Carcinoma by Targeting STAT3
    Mo Jie et al, 2022, Am. J. Chin. Med. CrossRef
  107. The Impact of Obesity, Adipose Tissue, and Tumor Microenvironment on Macrophage Polarization and Metastasis
    Ola Habanjar et al, 2022, Biology CrossRef
  108. CXCL8 in Tumor Biology and Its Implications for Clinical Translation
    Xingyu Xiong et al, 2022, Front. Mol. Biosci. CrossRef
  109. Hepatitis B–Induced IL8 Promotes Hepatocellular Carcinoma Venous Metastasis and Intrahepatic Treg Accumulation
    Changlu Zhang et al, 2021 CrossRef
  110. The JMJD Family Histone Demethylases in Crosstalk Between Inflammation and Cancer
    Jia Yang et al, 2022, Front. Immunol. CrossRef
  111. ILF2 Contributes to Hyperproliferation of Keratinocytes and Skin Inflammation in a KLHDC7B-DT-Dependent Manner in Psoriasis
    Xiran Yin et al, 2022, Front. Genet. CrossRef
  112. Deciphering Innate Immune Cell-Tumor Microenvironment Crosstalk at a Single-Cell Level
    Ryohichi Sugimura et al, 2022, Front. Cell Dev. Biol. CrossRef
  113. Interaction of M2 macrophages with hepatocellular carcinoma co-culture system in the presence of doxorubicin-loaded nanoparticles
    Mohammad Mahmoudian et al, 2022, Journal of Drug Delivery Science and Technology CrossRef
  114. Cell Trafficking at the Intersection of the Tumor–Immune Compartments
    Wenxuan Du et al, 2022, Annu. Rev. Biomed. Eng. CrossRef
  115. miR-203 Acts as an Inhibitor for Epithelial-Mesenchymal Transition Process in Diabetic Foot Ulcers via Targeting Interleukin-8.
    Liqin Yuan et al, 2019, Neuroimmunomodulation CrossRef
  116. Validation of a Preclinical Model of Diethylnitrosamine-Induced Hepatic Neoplasia in Yucatan Miniature Pigs.
    Jennifer Mitchell et al, 2016, Oncology CrossRef
  117. Crosstalk between tumor-associated macrophages and neighboring cells in hepatocellular carcinoma
    Pil Soo Sung, 2022, Clin Mol Hepatol CrossRef
  118. The Role of Inflammatory Cytokines in the Pathogenesis of Colorectal Carcinoma—Recent Findings and Review
    Jędrzej Borowczak et al, 2022, Biomedicines CrossRef
  119. Dual STAT‑3 and IL‑6R inhibition with stattic and tocilizumab decreases migration, invasion and proliferation of prostate cancer cells by targeting the IL‑6/IL‑6R/STAT‑3 axis
    Anibal Méndez‑Clemente et al, 2022, Oncol Rep CrossRef
  120. Analysis of invasiveness and tumor-associated macrophages infiltration in solid pseudopapillary tumors of pancreas
    Jie Yang et al, 2022, WJG CrossRef
  121. The role of tumor-associated macrophages and soluble mediators in pulmonary metastatic melanoma
    Kaifen Xiong et al, 2022, Front. Immunol. CrossRef
  122. Integrated analysis of novel macrophage related signature in anaplastic thyroid cancer
    Yi Luo et al, 2022, Endocrine CrossRef
  123. Plasticity towards Rigidity: A Macrophage Conundrum in Pulmonary Fibrosis
    Ezgi Sari et al, 2022, IJMS CrossRef
  124. The pro- and anti-tumoral properties of gap junctions in cancer and their role in therapeutic strategies
    Maria C. Oliveira et al, 2022, Redox Biology CrossRef
  125. Down-regulation of hepatic expression of GHR/STAT5/IGF-1 signaling pathway fosters development and aggressiveness of HCV-related hepatocellular carcinoma: Crosstalk with Snail-1 and type 2 transforming growth factor-beta receptor
    Mona A. Abu El-Makarem et al, 2022, PLoS ONE CrossRef
  126. Tremelimumab and durvalumab in the treatment of unresectable, advanced hepatocellular carcinoma
    Tiago Biachi de Castria et al, 2022, Future Oncology CrossRef
  127. Regulation of Epithelial-Mesenchymal Transition by Tumor Microenvironmental Signals and its Implication in Cancer Therapeutics
    Jing Zhang et al, 2022, Seminars in Cancer Biology CrossRef
  128. null
    Leena Arora et al, 2022 CrossRef
  129. Perspectives for novel therapeutic concepts in hepatocellular carcinoma targeting the stromal and innate immune microenvironment
    Charlotte Rennert et al, 2022, Liver Cancer International CrossRef
  130. Value of biomarkers in epithelial–mesenchymal transition models of liver cancer under different interventions: a meta-analysis
    Jing Yan et al, 2023, Future Oncology CrossRef
  131. Tumor−associated macrophage polarization in the inflammatory tumor microenvironment
    Zijuan Zou et al, 2023, Front. Oncol. CrossRef